Haleon plc (HLNCF)
OTCMKTS · Delayed Price · Currency is USD
4.830
+0.020 (0.42%)
At close: Dec 16, 2025
Haleon Market Cap
Haleon has a market cap or net worth of $43.46 billion as of December 16, 2025. Its market cap has increased by 0.46% in one year.
Market Cap
43.46B
Enterprise Value
54.10B
Revenue
15.10B
Ranking
n/a
PE Ratio
20.84
Stock Price
$4.83
Market Cap Chart
Since July 18, 2022, Haleon's market cap has increased from 34.14B to 43.46B, an increase of 27.28%. That is a compound annual growth rate of 7.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 43.97B | 2.79% |
| Dec 31, 2024 | 42.77B | 13.06% |
| Dec 29, 2023 | 37.83B | 3.87% |
| Dec 30, 2022 | 36.42B | 6.67% |
| Jul 18, 2022 | 34.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.79M |
| Glass House Brands | 723.84M |
| Elite Pharmaceuticals | 534.83M |
| CytoDyn | 383.23M |
| Northwest Biotherapeutics | 376.54M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 311.74M |
| Nika Pharmaceuticals | 285.90M |